Aussie study highlights hidden Hep C epidemic among baby boomers

Not all patients fit the injecting drug user stereotype, say experts
This content has been independently produced by ADG, made possible through sponsorship from Gilead.

The rapid uptake of direct-acting antiviral therapy to treat Hepatitis C virus has been credited with an estimated 30% reduction in deaths from advanced liver disease but not every infected patient is reaping the benefits of this recent treatment advance, an Australian study reveals.

hep c

Despite a relatively high treatment